Showing results (1251-1260 of 3,934) with videos related to
Sort By:
Pageof 394
American Journal of Cancer Research|October 17, 2024
Preoperative CT-based intra- and peri-tumoral radiomic models for differentiating benign and malignant tumors of the parotid gland: a two-center studyQian Shen, Cong Xiang, Kui Huang, et al.American Journal of Cancer Research|September 13, 2024
Fusobacterium nucleatum: a novel regulator of antitumor immune checkpoint blockade therapy in colorectal cancerMengjie Luo, Qi Li, Qingdan Gu, et al.American Journal of Cancer Research|September 13, 2024
PCMT1 confirmed as a pan-cancer immune biomarker and a contributor to breast cancer metastasisYiqi Liu, Haobing Li, Xiangyu Shen, et al.American Journal of Cancer Research|September 13, 2024
Targeted multimodal synergistic therapy of drug-resistant HER2-positive breast cancer by pyrotinib-ICG self-assembled nanoparticlesJuncheng Xuhong, Nisha Wu, Qiyun Shi, et al.American Journal of Cancer Research|September 13, 2024
Prognostic and immunological roles of RSPO1 in pan-cancer and its correlation with LUAD proliferation and metastasisXinqi Lou, Yuanyuan Wang, Yanjun Deng, et al.American Journal of Cancer Research|September 13, 2024
Machine learning models for prediction of lymph node metastasis in patients with T1b gastric cancerJi Won Seo, Ki Bum Park, Seung Taek Lim, et al.American Journal of Cancer Research|September 13, 2024
Effect of the thyroid transcription factor 1 expression and treatment discontinuation due to adverse events on progression-free survival in patients with advanced non-squamous non-small cell lung cancer treated with pembrolizumab plus pemetrexed and platinum chemotherapy: a Japanese four-hospital, retrospective studyShoma Mori, Takayoshi Maiguma, Keisuke Yoshii, et al.American Journal of Cancer Research|September 13, 2024
Nuclear factor-erythroid 2-related factor 3 (NRF3) is low expressed in colorectal cancer and its down-regulation promotes colorectal cancer malignance through activating EGFR and p38/MAPK [Retraction]American Journal of Cancer Research|October 17, 2024
Roles of clinical application of lenvatinib and its resistance mechanism in advanced hepatocellular carcinoma (Review)Ganghui Ye, Meng Ye, Xiaofeng JinAmerican Journal of Cancer Research|October 17, 2024
ZIP4: a promising early diagnostic and therapeutic targets for pancreatic cancerYunpeng Tang, Sheng Guo, Nianhui Yu, et al.Pageof 394